[Changes of iron metabolism indices in children with various genotypes of thalassema]

Yu-Jun Huang1, Shao-Guo Wu, Xiao-Bing Ou

  • 1Guangzhou Women and Children's Medical Center, Guangzhou 510120, China.

Insights

Serum iron (SI) and total iron-binding capacity (TIBC) are valuable for monitoring iron loading in children with thalassemia. Increased SI and decreased TIBC aid in diagnosing beta-0 thalassemia.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Clinical Chemistry

Context:

  • Thalassemia is a group of inherited blood disorders.
  • Accurate diagnosis and monitoring of iron metabolism are crucial in managing thalassemia.
  • Distinguishing between different types of thalassemia and iron deficiency anemia is essential for appropriate treatment.

Purpose:

  • To evaluate the diagnostic and monitoring value of serum iron (SI), total iron-binding capacity (TIBC), and transferrin (Tf) in children with various types of thalassemia and iron deficiency anemia (IDA).
  • To compare the effectiveness of SI, TIBC, and Tf in assessing iron loading in pediatric thalassemia patients.

Summary:

  • This study analyzed SI, TIBC, and Tf levels in children with silent alpha-thalassemia, standard alpha-thalassemia, HbH disease, beta-thalassemia (beta+ and beta0), and IDA, alongside healthy controls.
  • Results indicated that increased SI and decreased TIBC are significant indicators for beta-0 thalassemia, outperforming Tf in monitoring iron loading.
  • Transferrin levels were notably lower in silent and standard alpha-thalassemia compared to healthy children, while HbH disease showed lower TIBC and Tf.

Impact:

  • The findings suggest that SI and TIBC are more effective than Tf for monitoring iron overload in pediatric thalassemia.
  • These indices can aid in the specific diagnosis of beta-0 thalassemia in children presenting with anemia.
  • This research contributes to improved diagnostic strategies and patient management for thalassemia.
Abstract

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
63
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
54
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.4K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.5K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.4K